Clinical Trials@2x
  • News

    Most Read

    • Montreal Heart Institute reports positive results from Covid-19 trial
    • Telemedicine to benefit the most from remote patient monitoring tools: Poll
    • NIH reports full-dose blood thinners improve Covid-19 outcome

    Most Recent

    Clinical Trials

    Montreal Heart Institute reports positive results from Covid-19 trial

    25 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Montreal Heart Institute reports positive results from Covid-19 trial
    • Phase II Trial of Anti-Amyloid AR1001 Signals Little Promise for Patients with Alzheimer’s Disease
    • Telemedicine to benefit the most from remote patient monitoring tools: Poll

    Most Recent

    Clinical Trials

    Montreal Heart Institute reports positive results from Covid-19 trial

    25 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Sandoz Abandons US Development of Rixathon

Sandoz Abandons US Development of Rixathon

Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to...

6th February 2019
Industry Viewpoints: Patient Recruitment and Expanded Access

Industry Viewpoints: Patient Recruitment and Expanded Access

In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges...

30th January 2019
Industry Viewpoints: Choosing the Right CRO

Industry Viewpoints: Choosing the Right CRO

In this Industry Viewpoint, CTA’s Elizabeth Williams speaks with Philip Arlen to discuss key considerations...

12th December 2018
The United Kingdom of Green Britain

The United Kingdom of Green Britain

As medicinal cannabis hits the U.K., CTA’s Harry Parsons takes a look at the ground-breaking...

30th November 2018
Expert Insights: EMA Reinforces Stance on Biosimilar Use for Sustainable Health Care in New Educational Video

Expert Insights: EMA Reinforces Stance on Biosimilar Use for Sustainable Health Care in New Educational Video

Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the importance of the EMA’s efforts to...

19th October 2018
The Top 5: September 2018

The Top 5: September 2018

CTA highlights the best articles from the month of September 2018

1st October 2018
A Question to Sponsors – Have We Gone Too Far?

A Question to Sponsors – Have We Gone Too Far?

Jennifer Brandl, Clinical Trial Manager, Kezar Life Sciences, addresses a key hurdle to overcome to...

27th September 2018
Patient-Centric Clinical Trials │ How to Navigate the Clinical Trials Highway

Patient-Centric Clinical Trials │ How to Navigate the Clinical Trials Highway

Robert Greene, Founder and President, HungerNdThirst Foundation and Professional Patient, explains why patients should have...

25th September 2018
Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs?

Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs?

Peter Orosz, Head of Clinical Supply Chain Management & Oncology, Boehringer Ingelheim, addresses the challenges...

7th September 2018
Expert Insights: What Does the Future Hold for US Biosimilars?

Expert Insights: What Does the Future Hold for US Biosimilars?

Fern Barkalow, PhD, Oncology and Hematology Director, GlobalData, explores the future of biosimilars in light...

30th August 2018

Latest News

Clinical Trials

Montreal Heart Institute reports positive results from Covid-19 trial

25 Jan 2021
Technology

Telemedicine to benefit the most from remote patient monitoring tools: Poll

25 Jan 2021
Clinical Trials

NIH reports full-dose blood thinners improve Covid-19 outcome

25 Jan 2021
Clinical Trials

Senhwa Biosciences initiates enrolment in Covid-19 drug trial

25 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more